Shah Gaurav 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
Shah Gaurav
CEO
Transactions
- Sale
Common Stock
2024-08-16$18.50/sh−9,650$178,564→ 718,419 total
Holdings
- 207,897(indirect: By Spouse)
Common Stock
- 198,341(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.